Danhof, Sophia http://orcid.org/0000-0003-1316-0241
Rasche, Leo http://orcid.org/0000-0002-9536-9649
Mottok, Anja http://orcid.org/0000-0003-3125-0494
Steinmüller, Tabea
Zhou, Xiang http://orcid.org/0000-0003-3885-0919
Schreder, Martin
Kilian, Teresa http://orcid.org/0000-0002-2536-7664
Strifler, Susanne
Rosenwald, Andreas
Hudecek, Michael http://orcid.org/0000-0002-2280-2202
Einsele, Hermann http://orcid.org/0000-0002-7680-0819
Gerhard-Hartmann, Elena http://orcid.org/0000-0003-2134-2774
Funding for this research was provided by:
Dr. Mildred Scheel Stiftung für Krebsforschung (PD-02)
Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (ZZ-22)
Article History
Received: 18 November 2020
Accepted: 1 February 2021
First Online: 11 February 2021
Change Date: 3 April 2021
Change Type: Update
Change Details: OA funding needs to be added to fulfill the contractual requirement of the Compact agreement.
Declarations
:
: This study involving human participants was in accordance with the 1964 Helsinki Declaration and its later amendments and with the ethical standards of the institutional committee; the retrospective analysis of clinical data and evaluation of SLAMF7 expression on myeloma specimens were approved by the ethical committee of the Medical Faculty of the University of Wuerzburg (reference number: 61/18).
: Informed consent was obtained from all individual participants prior to invasive tissue sampling. Informed consent was obtained from all patients of whom material was included in this study, or, if patients were retrospectively identified to be included in this study and had passed away in the meantime, informed consent was obtained from their next of kin.
: Not applicable.
: The authors declare no competing interests.